Вы находитесь на странице: 1из 6

Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022

Persistence Market Research

Malignant Glioma Market: Global Industry

Analysis and Forecast 2016 - 2022

Persistence Market Research

Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022
Persistence Market Research Released New Market Report on Malignant Glioma Market:
Global Industry Analysis and Forecast 2016 - 2022.
Malignant gliomas are one of the common sub-type of primary brain tumors which are highly
invasive, aggressive and neurologically destructive tumors among the deadliest human cancers.
Gliomas account for around 45% of primary brain tumors where children are less likely to
develop the risk of gliomas. Gliomas arise from the glial cells or non-neuronal cells hence the
name and the cells are supposed to provide support and protection for neurons in the central
nervous system and peripheral nervous system. Gliomas are caused due to growing or invading
into or creating pressure in nearby the normal brain tissues developing tumors in the brain and
spinal cord. According to the grading by WHO (World Health Organization), the grade III tumors
are malignant and lead to death within 12 to 24 months. Currently more than 60% of the clinical
trials in gene therapy are focused on targeting cancer.
Cancer is one of the major and global health issue faced accounting for approximately 8 million
deaths globally. Heredity, geography, exposure to electromagnetic radiation and gender are
some factors responsible for most of the gliomas. There is no such population or geographies
where the risks for malignant glioblastoma is less hence the treatment area is much wide and
has large scope for future advancements. The factors which affect this market include the
limitations of chemotherapy, approvals rate for various drugs and therapies by regulatory bodies
and increasing population. Lifestyle changes is one of the leading factor to acceleration of this
market and indulge companies to select promising novel treatments entering the clinical arena.
The malignant glioma market can be segmented on the basis of therapy and distribution
Based on the therapy the malignant glioma market can be sun-divided into following:



Alkylating Agents

VEGF/VEGFR inhibitors

Anti angiogenic drugs

Based on the distribution channel the malignant glioma market can be sub-divided into the


Cancer Research Organizations

Persistence Market Research

Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022

Long term care centers

Diagnostic Centers

Pharmaceutical companies have made significant contributions in the treatment of cancer since
the past several decades along with increase in spending over cancer related R&D facilities.
The market for cancer is steadily increasing due to advancements in the novel methods of
treatment, product innovations and successful clinical trials conducted by pharmaceuticals.
There are various activities carried out by the pharmaceuticals globally to overcome the
technological challenges through mergers and acquisitions, funding and patents. Companies
operating in oncology segments are pre-registering for, Pre-clinical, IND, Phase I, Phase II,
Phase III.
Interested in report: Please follow the below the links to meet your requirements;
Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/10076
Depending on geographic region, malignant glioma is segmented into five key regions: North
America, Latin America, Europe, Asia Pacific, and Middle East & Africa. In the Malignant Glioma
Market the largest market share is gained by the U.S. where there are large incidence and
prevalence cases, followed by Europe where the major pharmaceuticals have their blockbuster
drugs and include the major funding associations. It is observed in a survey that 1 in 2 men and
1 in 3 women which accounts for almost 40% of the population in U.S. are at a risk of
developing cancer in the coming years. The drug development costs are overriding the costs of
investments in R&D and yet there are comparatively less approved drugs which pass the Phase
III trials. The developing countries as India and China have a higher scope by collaborating with
the large pharmaceutical industry players and develop new drugs.
Request TOC (table of content), Figures






The companies which are the major players in the malignant glioma market are Sigma-Aldrich
Co. LLC., Bristol-Myers Squibb, Genentech Inc. Sun Pharmaceutical Industries Ltd., Cipla Inc.,
Panacea Biotec., Zydus Cadila and Merck & Co., Inc.
The report covers exhaustive analysis on:

Malignant Glioma Market Segments

Malignant Glioma Market Dynamics

Historical Actual Market Size, 2013 - 2015

Persistence Market Research

Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022

Malignant Glioma Market Size & Forecast 2016 to 2022

Malignant Glioma Current Trends/Issues/Challenges

Competition & Companies involved

Malignant Glioma Drivers and Restraints

Regional analysis includes

North America

Latin America


Asia Pacific

Middle East & Africa

Follow us on LinkedIn: https://www.linkedin.com/company/persistence-market-research-&consulting

Report Highlights:

Shifting Industry dynamics

In-depth market segmentation

Historical, current and projected industry size Recent industry trends

Key Competition landscape

Strategies of key players and product offerings

Potential and niche segments/regions exhibiting promising growth

A neutral perspective towards market performance

For more Info: http://www.persistencemarketresearch.com/contact-us.asp

Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc
(as applicable)
2. The report covers geographic segmentation
North America

Persistence Market Research

Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022
3. The report provides the market size and forecast for the different segments and
geographies for the period of 2010 to 2020
4. The report provides company profiles of some of the leading companies operating in the
5. The report also provides porters five forces analysis of the market.
Browse the full All Upcoming Persistence Market's report at
About Us:
Persistence Market Research is a global market research firm specializing- syndicated
research, custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business.
As a full-service market research firm, we stand committed to bringing more accuracy and
speed to your business decisions. From ready-to-purchase market research reports to
customized global research solutions, our engagement models are highly flexible without
compromising on our deep-seated research values. Briefly stated, our mission is to give you
access to forecasts and trends analyses that put you on the path to profitability.
PMRs Services Go Beyond Gleaning Data:
Most enterprises believe that IT and databases are enough to make an accurate decision. While
we do not dispute that, consider this: How long does it take to make an accurate and strategic
million-dollar decision? We strive to deliver both even with demanding deadlines.

Facilitating Rapid and Informed Business Decisions

PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by
carefully balancing traditional and modern-day research methodologies.
Contact Us:
Addie Thomes
305 Broadway,
7th Floor,
New York City, NY 10007,
United States.
Phone: +1-646-568-7751

Persistence Market Research

Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022
USA/Canada Toll Free Number.
E-mail: Sales@persistencemarketresearch.com
Web : http://www.persistencemarketresearch.com/

Persistence Market Research